Amrita Krishnan, MD
I am director of the Judy and Bernard Briskin Center for Myeloma research at the City of Hope Cancer Center. I have been at City of Hope for 22 years after completing a fellowship in stem cell transplantation there. I have served as past chair of the BMT CTN myeloma group, and been the PI of several large CTN myeloma trials researching the role of post-transplant interventions to improve outcomes..
In addition I have been involved in Phase I trials of many of the new agents in myeloma including the anti CD38 antibodies and bispecific t cell engagers.I have served and chaired the ASCO plasma cell committee and CIBMTR plasma cell committee and serve as co-chair of the education committee for ASTCT. My current research efforts include understanding resistance mechanisms to antibodies and novel imaging methods for myeloma and I am leading the SWOG S1803 trial evaluating the role of MRD in directing maintenance therapy post autologous hematopoietic cell transplantation